Chapter 6. Characterization and Bioanalytical Aspects of Recombinant Proteins as Pharmaceutical Drugs
- Dr. Oliver Kayser,
- Prof. Dr. Rainer H. Müller
Published Online: 28 JAN 2005
DOI: 10.1002/3527602410.ch6
Copyright © 2004 Wiley-VCH Verlag GmbH & Co. KGaA
Book Title

Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications
Additional Information
How to Cite
Haunschild, J. and Kretzschmar, T. (2005) Characterization and Bioanalytical Aspects of Recombinant Proteins as Pharmaceutical Drugs, in Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications (eds O. Kayser and R. H. Müller), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527602410.ch6
Editor Information
Free University Berlin, Institute of Pharmacy, Pharmaceutical Technology, Biopharmacy & Biotechnology, Kelchstr. 31, 12169 Berlin, Germany
Publication History
- Published Online: 28 JAN 2005
- Published Print: 28 JAN 2004
ISBN Information
Print ISBN: 9783527305544
Online ISBN: 9783527602414
- Summary
- Chapter
Keywords:
- pharmaceutical biotechnology;
- characterization;
- bioanalytical aspects;
- recombinant proteins;
- pharmaceutical drugs;
- validation of bioanalytical assays;
- immunogenicity of recombinant proteins
Summary
Introduction
Characterization of Purified Recombinant Proteins
Purity and Impurities
Identity
Quantification of the Protein
Stability, Storage, and Sterility
Specificity and Cross-reactivity
Potency Determination
General Aspects and Assays
Potency Determination in Biological Matrices
Validation of Bioanalytical Assays
Method Establishment
Pre-study Validation
Selectivity
Assay Calibration
Accuracy and Precision
Linearity
Stability
In-study Validation
Immunogenicity of Recombinant Proteins
Examples
Factors Leading to Immune Responses
Methods to Determine Anti-protein Antibodies
Prediction of Immunogenicity of Therapeutic Proteins in Humans
References
